| abstract |
The present invention relates to a method for treating, preventing, deterring, suppressing, or reducing the incidence of diseases related to Androgen Decline in Female (ADIF) in female patients. Diseases related to ADIF include, for example, sexual dysfunction, decreased libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, modulation of mood and cognitive ability, depression, anemia, muscle weakness, alopecia, There are obesity, polycystic ovary, endometriosis, breast cancer, uterine cancer, and ovarian cancer. The method may be performed on a female patient with a selective androgen receptor modulator (SARM) compound, and / or an analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical, The process includes administering a hydrate, N-oxide, prodrug, polymorph, crystal, or any combination thereof. |